Science Explorer Back to mapMap
Discussion
Researcher · Biomedical Primate Research Centre · Netherlands

Michel Vierboom

Michel Vierboom publishes mostly in Immunology, Rheumatology and Molecular Biology, on topics such as Immunotherapy and Immune Responses, T-cell and B-cell Immunology and Rheumatoid Arthritis Research and Therapies.

ORCID 0000-0002-1865-7532 OpenAlex
World rank
#1,203,086
of 7,710,434 ranked researchers
Rank in Netherlands
#27,633
of 107,149
Works
59
Citations
3.7k
Citations per work
63.2
h-index
30
i10-index 39Top 15% in Immunology
Michel Vierboom

What does Michel Vierboom research?

Michel Vierboom's work is mostly in Immunology and Microbiology (39%), Medicine (33%), Biochemistry, Genetics and Molecular Biology (7%).

Life Sciences: 27 works · 46.0% of their workImmunology and Microbiology: 23 works · 39.0% of their workImmunology: 23 works · 39.0% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 7.0% of their workMolecular Biology: 4 works · 7.0% of their workHealth Sciences: 19 works · 32.6% of their workMedicine: 19 works · 32.6% of their workRheumatology: 8 works · 12.8% of their workOncology: 4 works · 7.0% of their workEpidemiology: 4 works · 6.4% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 6.4% of their workEverything else: 13 works · 21.4% of their workTHEIR WORKMichel Vierboom59works
Life Sciences46%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology2339.0%
    2. Biochemistry, Genetics and Molecular Biology47.0%
    1. Medicine1932.6%
  3. Everything else1321.4%
  1. 1Immunology39% of their works
  2. 2Rheumatology13% of their works
  3. 3Molecular Biology7% of their works
  4. 4Oncology7% of their works
  5. 5Epidemiology6% of their works
  6. 6Radiology, Nuclear Medicine and Imaging6% of their works

Research topics

Which keywords describe Michel Vierboom's research?

The keywords of their largest research topics: Antigen Presentation, Dendritic Cells, Immunity, Autoantibodies, Inflammation, Foxp3, TGF-ß and Biological Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Antigen Presentation292 topics
  2. Dendritic Cells231 topic
  3. Immunity231 topic
  4. Autoantibodies212 topics
  5. Inflammation192 topics
  6. Foxp3151 topic
  7. TGF-ß151 topic
  8. Biological Therapy141 topic
  9. Rheumatoid Arthritis141 topic
  10. Toll-like Receptors122 topics
  11. Fc Receptors91 topic
  12. NK Cell Recognition91 topic
  13. Natural Killer Cells91 topic
  14. Therapeutic Antibodies91 topic
  15. Antiphospholipid Syndrome71 topic
  16. Systemic Lupus Erythematosus71 topic
  17. Epitope Prediction61 topic
  18. Peptide-MHC Binding61 topic
  19. Innate Antiviral Responses51 topic
  20. Pattern Recognition Receptors51 topic

Where does Michel Vierboom work?

Michel Vierboom's main affiliation in the publication record is Biomedical Primate Research Centre, Netherlands.

How many publications and citations does Michel Vierboom have?

OpenAlex counts 59 works and 3,726 citations for Michel Vierboom, an h-index of 30, ranking #1,203,086 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michel Vierboom. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.